Advertisement
Canada markets open in 1 hour 34 minutes

  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CAD/USD

    0.7265
    +0.0002 (+0.02%)
     

  • CRUDE OIL

    82.26
    -0.47 (-0.57%)
     

  • Bitcoin CAD

    89,487.80
    +3,084.01 (+3.57%)
     

  • CMC Crypto 200

    1,339.70
    +27.08 (+2.11%)
     

  • GOLD FUTURES

    2,393.00
    -5.00 (-0.21%)
     

  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,488.25
    -59.00 (-0.34%)
     

  • VOLATILITY

    18.69
    +0.69 (+3.83%)
     

  • FTSE

    7,840.97
    -36.08 (-0.46%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6816
    -0.0005 (-0.07%)
     

Company News for July 21, 2017

Zacks Equity Research
Updated

•    Shares of Abbott Laboratories ABT gained 2.9% after the company reported second-quarter 2017 earnings of 62 cents per share, 3.3% higher than the Zacks Consensus Estimate


•    Shares of Kinder Morgan Inc KMI soared 4.5% after the company announced a dividend hike and a share-buyback plan


•    Shares of Philip Morris International Inc. PM declined 1.5% after the company reported second quarter earnings per share of $1.14 that missed the Zacks Consensus Estimate of $1.23


•    Shares of Travelers Companies Inc TRV dropped 1.5% after the company posted second-quarter 2017 earnings of $1.92 per share that missed the Zacks Consensus Estimate of $2.07
 


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Abbott Laboratories (ABT) : Free Stock Analysis Report
 
The Travelers Companies, Inc. (TRV) : Free Stock Analysis Report
 
Kinder Morgan, Inc. (KMI) : Free Stock Analysis Report
 
Philip Morris International Inc (PM) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research